<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aacou="http://abonyacquisitioncorpI.com/20260331"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aacou-20260331.xsd" xlink:type="simple"/>
    <context id="cref_373897767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1489176576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_78808507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1244046700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1755592433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">aacou:ProbabilityOfDeSPACAndInstrumentspecificMarketAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_846928445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1737341840">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_617820511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1027377133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1714581825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1084074997">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1192990110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1271755796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1433015701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_697426530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:BTIGLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1875495703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_475799433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_694894069">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_40338982">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_201454176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1666238458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1571238291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <startDate>2026-02-18</startDate>
            <endDate>2026-02-18</endDate>
        </period>
    </context>
    <context id="cref_2093904440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-20</instant>
        </period>
    </context>
    <context id="cref_1826633313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1888092448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1815466083">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1955056443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <startDate>2026-01-26</startDate>
            <endDate>2026-01-26</endDate>
        </period>
    </context>
    <context id="cref_1494685565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <instant>2026-01-26</instant>
        </period>
    </context>
    <context id="cref_287193436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-26</instant>
        </period>
    </context>
    <context id="cref_1164959796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-26</startDate>
            <endDate>2026-01-26</endDate>
        </period>
    </context>
    <context id="cref_1716804700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <startDate>2026-02-02</startDate>
            <endDate>2026-02-02</endDate>
        </period>
    </context>
    <context id="cref_245660575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-16</startDate>
            <endDate>2025-12-16</endDate>
        </period>
    </context>
    <context id="cref_492339568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-16</startDate>
            <endDate>2025-12-16</endDate>
        </period>
    </context>
    <context id="cref_984596877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-16</startDate>
            <endDate>2025-12-16</endDate>
        </period>
    </context>
    <context id="cref_749400756">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:InitialShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-28</startDate>
            <endDate>2025-11-28</endDate>
        </period>
    </context>
    <context id="cref_1413226857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-28</instant>
        </period>
    </context>
    <context id="cref_21244380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">aacou:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-28</startDate>
            <endDate>2025-11-28</endDate>
        </period>
    </context>
    <context id="cref_105683079">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivatePlacementWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1630215272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:BTIGLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1670301127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_475759915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivatePlacementWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_1995627856">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1513325083">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1581599079">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_158500031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1258609701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_562520141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aacou:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_586599417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_889495524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_16850283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1835552445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aacou:PublicShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1748864495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aacou:PublicShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_599808219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_249744129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_648568085">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_248130894">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1661469033">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_1382974176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:BTIGLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_1256576430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_862390686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_238978682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="cref_753855685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_470747820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_937058561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_2040513409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_614682273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1676999742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1461188081">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_282190116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1011651767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1802655610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1446535399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1483589274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2033277279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1071478003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-20</startDate>
            <endDate>2026-02-20</endDate>
        </period>
    </context>
    <context id="cref_733670977">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">aacou:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_601070052">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_259384816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1219998298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-11</instant>
        </period>
    </context>
    <context id="cref_501601786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-11</instant>
        </period>
    </context>
    <context id="cref_8645472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aacou:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAt1150PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_2073724703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aacou:ClassAOrdinaryShareParValue00001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_565888671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aacou:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_162669624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1727728256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1638241348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_230942018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1507025034">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_658415028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002099906</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <unit id="uref_1548609138">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_78808507">
        <measure>pure</measure>
    </unit>
    <unit id="uref_1737341840">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_1714581825">
        <measure>shares</measure>
    </unit>
    <unit id="uref_1509847698">
        <measure>aacou:Segment</measure>
    </unit>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1489176576"
      id="fc_809433895"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1489176576"
      id="fc_1874977205"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <aacou:WorkingCapitalLoansOutstanding
      contextRef="cref_1489176576"
      id="fc_1127746005"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_373897767" id="fc_824299840">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_1489176576"
      id="fc_840869526"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_1489176576"
      id="fc_1510133105"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <aacou:PrepaidInsuranceCurrent
      contextRef="cref_1802655610"
      id="fc_1519547833"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1802655610"
      id="fc_1736271392"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:DeferredCosts
      contextRef="cref_1489176576"
      id="fc_1885260520"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <aacou:PrepaidInsuranceNonCurrent
      contextRef="cref_1802655610"
      id="fc_1650712957"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1802655610"
      id="fc_420633687"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_162669624"
      id="fc_162669624"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <aacou:DeferredUnderwritingFeePayableNoncurrent
      contextRef="cref_1802655610"
      id="fc_442742033"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_1489176576"
      id="fc_1779702615"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_1802655610"
      id="fc_1364654189"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_601070052"
      id="fc_902607472"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_1489176576"
      id="fc_1466685186"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_1802655610"
      id="fc_154480557"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="cref_601070052"
      id="fc_617085257"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_1489176576"
      id="fc_573856785"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_601070052"
      id="fc_249510928"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_601070052"
      id="fc_1568397196"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1802655610"
      id="fc_1768603609"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1802655610"
      id="fc_294408262"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_601070052"
      id="fc_1443578983"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <dei:CurrentFiscalYearEndDate contextRef="cref_373897767" id="fc_398220996">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1011651767"
      id="fc_1612943651"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1727728256"
      id="fc_1727728256"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <aacou:SaleOfPrivatePlacementUnits
      contextRef="cref_1727728256"
      id="fc_1815507275"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <aacou:SaleOfPrivatePlacementUnits
      contextRef="cref_1461188081"
      id="fc_975862712"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <aacou:SaleOfPrivatePlacementUnitsInShares
      contextRef="cref_1727728256"
      id="fc_1026691934"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1011651767"
      id="fc_925251574"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1727728256"
      id="fc_1975712472"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1461188081"
      id="fc_917862301"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1802655610"
      id="fc_2029586813"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1802655610"
      id="fc_1787106116"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1802655610"
      id="fc_1408171859"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_601070052"
      id="fc_783149177"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_601070052"
      id="fc_1676091037"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1638241348"
      id="fc_1638241348"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:NumberOfOperatingSegments
      contextRef="cref_373897767"
      decimals="0"
      id="fc_1509847698"
      unitRef="uref_1509847698">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1802655610"
      id="fc_1152767363"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1802655610"
      id="fc_1257738491"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_230942018"
      id="fc_230942018"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_230942018"
      id="fc_589068535"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1507025034"
      id="fc_1507025034"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1507025034"
      id="fc_315444340"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_658415028"
      id="fc_658415028"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1011651767"
      id="fc_945349948"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1727728256"
      id="fc_267422993"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1461188081"
      id="fc_247630095"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1011651767"
      id="fc_1949308211"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1727728256"
      id="fc_1692467812"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_282190116"
      id="fc_1140327473"
      unitRef="uref_1548609138"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1433015701"
      id="fc_1140432218"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1433015701"
      id="fc_1992290329"
      unitRef="uref_1714581825"
      xsi:nil="true"/>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_373897767" id="ixv-3104">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="cref_373897767" id="ixv-3105">0002099906</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="cref_373897767" id="ixv-3106">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="cref_373897767" id="ixv-3791">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_373897767" id="ixv-3792">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_373897767" id="ixv-28">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_373897767" id="ixv-3793">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_373897767" id="ixv-3794">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_373897767" id="ixv-3795">001-43133</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_373897767" id="ixv-3796">Abony Acquisition Corp. I</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_373897767" id="ixv-3797">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="cref_373897767" id="ixv-3798">98-1932335</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_373897767" id="ixv-3799">1700     S Lamar Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_373897767" id="ixv-3800">Suite #338</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_373897767" id="ixv-3801">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_373897767" id="ixv-3802">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_373897767" id="ixv-3803">78704</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_373897767" id="ixv-3804">(512)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_373897767" id="ixv-3805">553-1770</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_565888671" id="ixv-3806">Units,     each consisting of one Class A ordinary share and one-third of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_565888671" id="ixv-3807">AACOU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_565888671" id="ixv-3808">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_2073724703" id="ixv-3809">Class     A ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_2073724703" id="ixv-3810">AACO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_2073724703" id="ixv-3811">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_8645472" id="ixv-3812">Warrants,     each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_8645472" id="ixv-3813">AACOW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_8645472" id="ixv-3814">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_373897767" id="ixv-3815">No</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_373897767" id="ixv-3816">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_373897767" id="ixv-3817">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_373897767" id="ixv-3818">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_373897767" id="ixv-3819">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_373897767" id="ixv-3820">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_373897767" id="ixv-3821">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_501601786"
      decimals="0"
      id="ixv-3822"
      unitRef="uref_1714581825">23695000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1219998298"
      decimals="0"
      id="ixv-3823"
      unitRef="uref_1714581825">7666667</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3824"
      unitRef="uref_1548609138">1324398</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3825"
      unitRef="uref_1548609138">83096</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3826"
      unitRef="uref_1548609138">40000</us-gaap:PrepaidExpenseCurrent>
    <aacou:PrepaidInsuranceCurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3827"
      unitRef="uref_1548609138">60312</aacou:PrepaidInsuranceCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3828"
      unitRef="uref_1548609138">1467806</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3829"
      unitRef="uref_1548609138">40000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCosts
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3830"
      unitRef="uref_1548609138">351275</us-gaap:DeferredCosts>
    <aacou:PrepaidInsuranceNonCurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="fc_340257626"
      unitRef="uref_1548609138">53132</aacou:PrepaidInsuranceNonCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3832"
      unitRef="uref_1548609138">230828386</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3833"
      unitRef="uref_1548609138">232349324</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3834"
      unitRef="uref_1548609138">391275</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3835"
      unitRef="uref_1548609138">83131</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3836"
      unitRef="uref_1548609138">33875</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <aacou:AccruedOfferingCosts
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3837"
      unitRef="uref_1548609138">109083</aacou:AccruedOfferingCosts>
    <aacou:AccruedOfferingCosts
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3838"
      unitRef="uref_1548609138">307325</aacou:AccruedOfferingCosts>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_259384816"
      decimals="0"
      id="ixv-3839"
      unitRef="uref_1548609138">124790</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3840"
      unitRef="uref_1548609138">192214</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3841"
      unitRef="uref_1548609138">465990</us-gaap:LiabilitiesCurrent>
    <aacou:DeferredUnderwritingFeePayableNoncurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3842"
      unitRef="uref_1548609138">8050000</aacou:DeferredUnderwritingFeePayableNoncurrent>
    <us-gaap:Liabilities
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3843"
      unitRef="uref_1548609138">8242214</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3844"
      unitRef="uref_1548609138">465990</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital
      contextRef="cref_1271755796"
      decimals="4"
      id="ixv-3845"
      unitRef="uref_1548609138">0.0001</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
    <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital
      contextRef="cref_601070052"
      decimals="4"
      id="ixv-3846"
      unitRef="uref_1548609138">0.0001</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-3847"
      unitRef="uref_1714581825">23000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_1271755796"
      decimals="2"
      id="ixv-3848"
      unitRef="uref_1737341840">10.04</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_601070052"
      decimals="0"
      id="ixv-3849"
      unitRef="uref_1737341840">0</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-3850"
      unitRef="uref_1548609138">230828386</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_1489176576"
      decimals="4"
      id="ixv-3851"
      unitRef="uref_1737341840">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_1802655610"
      decimals="4"
      id="ixv-3852"
      unitRef="uref_1737341840">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3853"
      unitRef="uref_1714581825">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3854"
      unitRef="uref_1714581825">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1271755796"
      decimals="4"
      id="ixv-3855"
      unitRef="uref_1737341840">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_601070052"
      decimals="4"
      id="ixv-3856"
      unitRef="uref_1737341840">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_601070052"
      decimals="0"
      id="fc_601070052"
      unitRef="uref_1714581825">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-3858"
      unitRef="uref_1714581825">695000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1271755796"
      decimals="0"
      id="fc_1503150033"
      unitRef="uref_1714581825">695000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-3860"
      unitRef="uref_1548609138">70</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1084074997"
      decimals="4"
      id="fc_1877463656"
      unitRef="uref_1737341840">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1192990110"
      decimals="4"
      id="fc_1100698523"
      unitRef="uref_1737341840">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1084074997"
      decimals="0"
      id="fc_504481387"
      unitRef="uref_1714581825">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1192990110"
      decimals="0"
      id="fc_334448824"
      unitRef="uref_1714581825">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1084074997"
      decimals="0"
      id="fc_1118528897"
      unitRef="uref_1714581825">7666667</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1084074997"
      decimals="0"
      id="fc_1050704979"
      unitRef="uref_1714581825">7666667</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1192990110"
      decimals="0"
      id="fc_462183430"
      unitRef="uref_1714581825">7666667</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1192990110"
      decimals="0"
      id="fc_759636953"
      unitRef="uref_1714581825">7666667</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_1084074997"
      decimals="0"
      id="fc_12832729"
      unitRef="uref_1548609138">767</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_1192990110"
      decimals="0"
      id="fc_380740556"
      unitRef="uref_1548609138">767</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3871"
      unitRef="uref_1548609138">24233</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3872"
      unitRef="uref_1548609138">-6722113</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3873"
      unitRef="uref_1548609138">-99715</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3874"
      unitRef="uref_1548609138">-6721276</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3875"
      unitRef="uref_1548609138">-74715</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3876"
      unitRef="uref_1548609138">232349324</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3877"
      unitRef="uref_1548609138">391275</us-gaap:LiabilitiesAndStockholdersEquity>
    <aacou:NumberOfOrdinarySharesSubjectToForfeitureIfTheOverallotmentOptionIsNotExercised
      contextRef="cref_1084074997"
      decimals="0"
      id="ixv-3879"
      unitRef="uref_1714581825">1000000</aacou:NumberOfOrdinarySharesSubjectToForfeitureIfTheOverallotmentOptionIsNotExercised>
    <aacou:AdditionalFounderSharesIssued
      contextRef="cref_733670977"
      decimals="0"
      id="ixv-3880"
      unitRef="uref_1714581825">1916667</aacou:AdditionalFounderSharesIssued>
    <aacou:NumberOfSharesHeldByTheSponsor
      contextRef="cref_733670977"
      decimals="0"
      id="fc_733670977"
      unitRef="uref_1714581825">7666667</aacou:NumberOfSharesHeldByTheSponsor>
    <aacou:NumberOfSharesAreNoLongerSubjectToForfeiture
      contextRef="cref_1714581825"
      decimals="0"
      id="ixv-3882"
      unitRef="uref_1714581825">1000000</aacou:NumberOfSharesAreNoLongerSubjectToForfeiture>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3883"
      unitRef="uref_1548609138">282307</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3884"
      unitRef="uref_1548609138">-282307</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3885"
      unitRef="uref_1548609138">828386</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3886"
      unitRef="uref_1548609138">828386</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3887"
      unitRef="uref_1548609138">546079</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3888"
      unitRef="uref_1714581825">10267833</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1513325083"
      decimals="2"
      id="ixv-3889"
      unitRef="uref_1737341840">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3890"
      unitRef="uref_1714581825">10267833</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1513325083"
      decimals="2"
      id="ixv-3891"
      unitRef="uref_1737341840">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_889495524"
      decimals="0"
      id="fc_996730341"
      unitRef="uref_1714581825">7100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_889495524"
      decimals="2"
      id="ixv-3893"
      unitRef="uref_1737341840">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_889495524"
      decimals="0"
      id="fc_1309080258"
      unitRef="uref_1714581825">7666667</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_889495524"
      decimals="2"
      id="ixv-3895"
      unitRef="uref_1737341840">0.03</us-gaap:EarningsPerShareDiluted>
    <aacou:NumberOfOrdinarySharesSubjectToForfeitureIfOverallotmentOptionIsNotExercised
      contextRef="cref_889495524"
      decimals="0"
      id="ixv-3897"
      unitRef="uref_1714581825">1000000</aacou:NumberOfOrdinarySharesSubjectToForfeitureIfOverallotmentOptionIsNotExercised>
    <aacou:NumberOfOrdinarySharesFullyExercisedTheirOverallotmentOption
      contextRef="cref_1071478003"
      decimals="0"
      id="ixv-3898"
      unitRef="uref_1714581825">1000000</aacou:NumberOfOrdinarySharesFullyExercisedTheirOverallotmentOption>
    <us-gaap:SharesOutstanding
      contextRef="cref_2033277279"
      decimals="0"
      id="fc_1466992512"
      unitRef="uref_1714581825">7666667</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_2033277279"
      decimals="0"
      id="ixv-3900"
      unitRef="uref_1548609138">767</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1483589274"
      decimals="0"
      id="ixv-3901"
      unitRef="uref_1548609138">24233</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1446535399"
      decimals="0"
      id="ixv-3902"
      unitRef="uref_1548609138">-99715</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1802655610"
      decimals="0"
      id="ixv-3903"
      unitRef="uref_1548609138">-74715</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_282190116"
      decimals="0"
      id="ixv-3904"
      unitRef="uref_1548609138">-9374554</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1461188081"
      decimals="0"
      id="ixv-3905"
      unitRef="uref_1548609138">-7168477</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3906"
      unitRef="uref_1548609138">16543031</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <aacou:SaleOfPrivatePlacementUnitsInShares
      contextRef="cref_1011651767"
      decimals="0"
      id="ixv-3907"
      unitRef="uref_1714581825">695000</aacou:SaleOfPrivatePlacementUnitsInShares>
    <aacou:SaleOfPrivatePlacementUnits
      contextRef="cref_1011651767"
      decimals="0"
      id="ixv-3908"
      unitRef="uref_1548609138">70</aacou:SaleOfPrivatePlacementUnits>
    <aacou:SaleOfPrivatePlacementUnits
      contextRef="cref_282190116"
      decimals="0"
      id="ixv-3909"
      unitRef="uref_1548609138">6949930</aacou:SaleOfPrivatePlacementUnits>
    <aacou:SaleOfPrivatePlacementUnits
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3910"
      unitRef="uref_1548609138">6950000</aacou:SaleOfPrivatePlacementUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_282190116"
      decimals="0"
      id="ixv-3911"
      unitRef="uref_1548609138">2568333</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3912"
      unitRef="uref_1548609138">2568333</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_282190116"
      decimals="0"
      id="ixv-3913"
      unitRef="uref_1548609138">167942</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3914"
      unitRef="uref_1548609138">167942</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1461188081"
      decimals="0"
      id="ixv-3915"
      unitRef="uref_1548609138">546079</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3916"
      unitRef="uref_1548609138">546079</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_1676999742"
      decimals="0"
      id="fc_957446115"
      unitRef="uref_1714581825">7666667</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1676999742"
      decimals="0"
      id="ixv-3918"
      unitRef="uref_1548609138">767</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_614682273"
      decimals="0"
      id="ixv-3919"
      unitRef="uref_1548609138">-6722113</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3920"
      unitRef="uref_1548609138">-6721276</us-gaap:StockholdersEquity>
    <aacou:NumberOfOrdinarySharesSubjectToForfeitureIfOverallotmentOptionIsNotExercised
      contextRef="cref_2040513409"
      decimals="0"
      id="ixv-3922"
      unitRef="uref_1714581825">1000000</aacou:NumberOfOrdinarySharesSubjectToForfeitureIfOverallotmentOptionIsNotExercised>
    <aacou:AdditionalFounderIssuedShare
      contextRef="cref_937058561"
      decimals="0"
      id="ixv-3923"
      unitRef="uref_1714581825">1916667</aacou:AdditionalFounderIssuedShare>
    <aacou:NumberOfSharesHeldBySponsor
      contextRef="cref_470747820"
      decimals="0"
      id="fc_470747820"
      unitRef="uref_1714581825">7666667</aacou:NumberOfSharesHeldBySponsor>
    <aacou:NumberOfOrdinarySharesFullyExercisedTheirOverallotmentOption
      contextRef="cref_753855685"
      decimals="0"
      id="ixv-3925"
      unitRef="uref_1714581825">1000000</aacou:NumberOfOrdinarySharesFullyExercisedTheirOverallotmentOption>
    <us-gaap:NetIncomeLoss
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3926"
      unitRef="uref_1548609138">546079</us-gaap:NetIncomeLoss>
    <aacou:PaymentOfOperationCostsThroughPromissoryNote
      contextRef="cref_373897767"
      decimals="0"
      id="fc_385385652"
      unitRef="uref_1548609138">-29799</aacou:PaymentOfOperationCostsThroughPromissoryNote>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3928"
      unitRef="uref_1548609138">828386</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3929"
      unitRef="uref_1548609138">5596</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <aacou:IncreaseDecreaseInPrepaidInsuranceCurrent
      contextRef="cref_373897767"
      decimals="0"
      id="fc_1638061308"
      unitRef="uref_1548609138">60312</aacou:IncreaseDecreaseInPrepaidInsuranceCurrent>
    <aacou:IncreaseDecreaseInPrepaidInsuranceLongTerm
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3931"
      unitRef="uref_1548609138">53132</aacou:IncreaseDecreaseInPrepaidInsuranceLongTerm>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3932"
      unitRef="uref_1548609138">49256</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3933"
      unitRef="uref_1548609138">-322292</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <aacou:InvestmentOfCashInTrustAccount
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3934"
      unitRef="uref_1548609138">-230000000</aacou:InvestmentOfCashInTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3935"
      unitRef="uref_1548609138">-230000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <aacou:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3936"
      unitRef="uref_1548609138">225400000</aacou:ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3937"
      unitRef="uref_1548609138">6950000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3938"
      unitRef="uref_1548609138">302954</us-gaap:RepaymentsOfRelatedPartyDebt>
    <aacou:PaymentOfOfferingCosts
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3939"
      unitRef="uref_1548609138">400356</aacou:PaymentOfOfferingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3940"
      unitRef="uref_1548609138">231646690</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_373897767"
      decimals="0"
      id="fc_1523412680"
      unitRef="uref_1548609138">1324398</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3942"
      unitRef="uref_1548609138">1324398</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <aacou:DeferredOfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3943"
      unitRef="uref_1548609138">71835</aacou:DeferredOfferingCostsIncludedInAccruedOfferingCosts>
    <aacou:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3944"
      unitRef="uref_1548609138">70865</aacou:DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty>
    <aacou:PrepaidExpensesPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3945"
      unitRef="uref_1548609138">37500</aacou:PrepaidExpensesPaidThroughPromissoryNoteRelatedParty>
    <aacou:DeferredUnderwritingFeePayable
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3946"
      unitRef="uref_1548609138">8050000</aacou:DeferredUnderwritingFeePayable>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_373897767" id="ixv-1625">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note 1 &#x2014; Organization and Business Operations&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Abony Acquisition Corp.&#160;I (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Cayman Islands exempted company on November&#160;13, 2025. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company has not selected any specific Business Combination target, and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business Combination with the Company. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March 31, 2026, the Company has not commenced any operations. All activity for the period from November&#160;13, 2025 (inception) through March 31, 2026 relates to the Company&#x2019;s formation, Initial Public Offering (the &#x201c;Initial Public Offering&#x201d;), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company may generate non-operating income in the form of interest income on the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company&#x2019;s sponsor is Abony Sponsor&#160;I LLC (the &#x201c;Sponsor&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on January 30, 2026. On February 20, 2026, the Company consummated its Initial Public Offering, which consisted of 23,000,000 units (the &#x201c;Units&#x201d;), including the exercise in full by the underwriter of an option to purchase up to 3,000,000 Units at the offering price to cover over-allotments. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 695,000 units (the &#x201c;Private Placement Units&#x201d;) to the Sponsor and BTIG, LLC, the representative of the underwriter, at $10.00 per Unit, generating gross proceeds of $6,950,000. Of those 695,000 Private Placement Units, the Sponsor purchased 465,000 Private Placement Units and BTIG, LLC purchased 230,000 Private Placement Units. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Each Unit consists of one Class A ordinary share (the &#x201c;Public Shares&#x201d;) and one-third of one redeemable warrant (the &#x201c;Public Warrants&#x201d;). Each Private Placement Unit consists of one Class A ordinary share (the &#x201c;Private Placement Share&#x201d;) and one-third of one redeemable warrant (the &#x201c;Private Placement Warrant&#x201d;). Each whole Public Warrant and Private Placement Warrant (together, the &#x201c;Warrants&#x201d;) entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Transaction costs amounted to $13,314,254, consisting of $4,600,000 of cash underwriting fee, $8,050,000 of deferred underwriting fee, and $664,254 of other offering costs. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement Units, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting commissions).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company&#x2019;s Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act&#160;of&#160;1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company will be able to successfully effect a Business Combination. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Following the closing of the Initial Public Offering on February 20, 2026, an amount of $230,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units, and a portion of the net proceeds from the sale of the Private Placement Units, was held in a trust account (the &#x201c;Trust Account&#x201d;) and initially invested only in U.S.&#160;government treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act which invest only in direct U.S.&#160;government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based on the management team&#x2019;s ongoing assessment of all factors related to the Company&#x2019;s potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the sale of the Private Placement Units&#160;will not be released from the Trust Account until the earliest of (i)&#160;the completion of the Company&#x2019;s initial Business Combination, (ii)&#160;the redemption of the Company&#x2019;s Public Shares if the Company is unable to complete the initial Business Combination within 24&#160;months from the closing of the Initial Public Offering or by such earlier liquidation date as the Company&#x2019;s board of directors may approve (the &#x201c;Completion Window&#x201d;), subject to applicable law, or (iii)&#160;the redemption of the Company&#x2019;s Public Shares properly submitted in connection with a shareholder vote to amend the Company&#x2019;s amended and restated memorandum and articles of association to (A)&#160;modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company&#x2019;s Public Shares if the Company has not consummated an initial Business Combination within the Completion Window or (B)&#160;with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s public shareholders. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company will provide the Company&#x2019;s public shareholders with the opportunity to redeem all or a portion of their Public Shares, regardless of whether they abstain, vote for, or vote against, an initial Business Combination upon completion of the initial Business Combination either (i)&#160;in connection with a general meeting called to approve the initial Business Combination or (ii)&#160;without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two&#160;business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable), divided by the number of then outstanding Public Shares, subject to the limitations. The amount deposited in the Trust Account at the time of the Initial Public Offering was $10.00 per Public Share. The Public Shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;480, &#x201c;Distinguishing Liabilities from Equity.&#x201d; &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company has only the duration of the Completion Window to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Completion Window, the Company will as promptly as reasonably possible but not more than ten&#160;business days thereafter (and subject to lawfully available funds therefor), redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will constitute full and complete payment for the Public Shares and completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Sponsor, officers and directors (&#x201c;Initial Shareholders&#x201d;) entered into a letter agreement with the Company, pursuant to which they agree to waive their redemption rights with respect to any shares held by them in connection with the completion of an initial Business Combination. Additionally, the Sponsor, officers and directors will agree to waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and Private Placement Shares if Company fails to complete an initial Business Combination within the prescribed time frame, although they will be entitled to liquidating distributions from assets outside the Trust Account. If the Company does not complete the initial Business Combination within the prescribed time frame, the Private Placement Units&#160;(and the securities comprising such units) will be worthless. Furthermore, the Initial Shareholders will agree not to transfer, assign or sell any of their founder shares and any Class&#160;A ordinary shares issuable upon conversion thereof until the earlier to occur of (i)&#160;six months after the completion of the initial Business Combination or (ii)&#160;the date following the completion of the initial Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, (1)&#160;if the closing price of the Class&#160;A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20&#160;trading days within any 30-trading&#160;day period commencing at least 30&#160;days after the initial Business Combination or (2)&#160;if the Company consummates a transaction after the initial Business Combination which results in the shareholders having the right to exchange their shares for cash, securities or other property, the founder shares will be released from the lock-up. The Private Placement Units&#160;(including the securities comprising such units and the Class&#160;A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable until 30&#160;days following the completion of the initial Business Combination. Because each of the officers and directors will own ordinary shares or units directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate an initial Business Combination. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company&#x2019;s Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i)&#160;$10.00 per Public Share and (ii)&#160;the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act&#160;of&#160;1933, as amended (the &#x201c;Securities Act&#x201d;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Liquidity, Capital Resources and Going Concern&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; As of March 31, 2026, the Company had $1,324,398 in cash and had working capital of $1,275,592. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $1,500,000 of the Working Capital Loans may be converted upon completion of a Business Combination into private units at a price of $10.00 per unit. Such private units would be identical to the Private Placement Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of March 31, 2026, there were no Working Capital Loans outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with FASB ASC 205-40, &#x201c;Presentation of Financial Statements - Going Concern,&#x201d; the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. The Company has the Completion Window to complete the initial Business Combination. Management has determined that the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the unaudited condensed financial statements.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_373897767" id="ixv-3947">2025-11-13</dei:EntityIncorporationDateOfIncorporation>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_248130894"
      decimals="0"
      id="ixv-3948"
      unitRef="uref_1714581825">23000000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_238978682"
      decimals="0"
      id="ixv-3949"
      unitRef="uref_1714581825">3000000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_248130894"
      decimals="2"
      id="ixv-3950"
      unitRef="uref_1737341840">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1661469033"
      decimals="0"
      id="ixv-3951"
      unitRef="uref_1548609138">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1995627856"
      decimals="0"
      id="ixv-3952"
      unitRef="uref_1714581825">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1995627856"
      decimals="2"
      id="ixv-3953"
      unitRef="uref_1737341840">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_862390686"
      decimals="0"
      id="ixv-3954"
      unitRef="uref_1548609138">6950000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1995627856"
      decimals="0"
      id="ixv-3955"
      unitRef="uref_1714581825">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1256576430"
      decimals="0"
      id="ixv-3956"
      unitRef="uref_1714581825">465000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1382974176"
      decimals="0"
      id="ixv-3957"
      unitRef="uref_1714581825">230000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_158500031"
      decimals="2"
      id="fc_1190564010"
      unitRef="uref_1737341840">11.5</us-gaap:SharesIssuedPricePerShare>
    <aacou:TransactionCosts
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3959"
      unitRef="uref_1548609138">13314254</aacou:TransactionCosts>
    <aacou:CashUnderwritingFee
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3960"
      unitRef="uref_1548609138">4600000</aacou:CashUnderwritingFee>
    <aacou:DeferredUnderwritingFee
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3961"
      unitRef="uref_1548609138">8050000</aacou:DeferredUnderwritingFee>
    <aacou:OtherOfferingCosts
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3962"
      unitRef="uref_1548609138">664254</aacou:OtherOfferingCosts>
    <aacou:PercentageOfFairMarketValueNetAssetsHeldInTrustAccount
      contextRef="cref_373897767"
      decimals="2"
      id="ixv-3963"
      unitRef="uref_78808507">0.80</aacou:PercentageOfFairMarketValueNetAssetsHeldInTrustAccount>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="cref_249744129"
      decimals="2"
      id="ixv-3964"
      unitRef="uref_78808507">0.50</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1661469033"
      decimals="0"
      id="ixv-3965"
      unitRef="uref_1548609138">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_248130894"
      decimals="2"
      id="ixv-3966"
      unitRef="uref_1737341840">10</us-gaap:SaleOfStockPricePerShare>
    <aacou:InvestmentMaturityTerm contextRef="cref_648568085" id="ixv-3967">P185D</aacou:InvestmentMaturityTerm>
    <aacou:PercentageOfRedemptionOnPublicShares
      contextRef="cref_249744129"
      decimals="2"
      id="ixv-3968"
      unitRef="uref_78808507">1</aacou:PercentageOfRedemptionOnPublicShares>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1748864495"
      decimals="2"
      id="fc_1665422819"
      unitRef="uref_1737341840">10</us-gaap:SharesIssuedPricePerShare>
    <aacou:MinimumAmountPaymentForDissolutionExpenses
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-3970"
      unitRef="uref_1548609138">100000</aacou:MinimumAmountPaymentForDissolutionExpenses>
    <aacou:ClosingPriceOfOrdinaryShareEqualOrExceed
      contextRef="cref_1271755796"
      decimals="2"
      id="ixv-3971"
      unitRef="uref_1737341840">12</aacou:ClosingPriceOfOrdinaryShareEqualOrExceed>
    <aacou:NumberOfTradingDays contextRef="cref_599808219" id="fc_599808219">P20D</aacou:NumberOfTradingDays>
    <aacou:NumberOfTradingDays contextRef="cref_373897767" id="fc_440051650">P30D</aacou:NumberOfTradingDays>
    <aacou:NumberOfTradingDays contextRef="cref_373897767" id="fc_951160203">P30D</aacou:NumberOfTradingDays>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1748864495"
      decimals="2"
      id="fc_1748864495"
      unitRef="uref_1737341840">10</us-gaap:SharesIssuedPricePerShare>
    <aacou:PerPublicShare
      contextRef="cref_1835552445"
      decimals="2"
      id="ixv-3976"
      unitRef="uref_1737341840">10</aacou:PerPublicShare>
    <us-gaap:Cash
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3977"
      unitRef="uref_1548609138">1324398</us-gaap:Cash>
    <aacou:WorkingCapitalDeficit
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3978"
      unitRef="uref_1548609138">1275592</aacou:WorkingCapitalDeficit>
    <aacou:WorkingCapitalLoans
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3979"
      unitRef="uref_1548609138">1500000</aacou:WorkingCapitalLoans>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="cref_16850283"
      decimals="2"
      id="ixv-3980"
      unitRef="uref_1737341840">10</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_373897767" id="ixv-1721">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note 2 &#x2014; Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Certain information or footnote disclosures normally included in  financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s prospectus for its Initial Public Offering as filed with the SEC on February 19, 2026, the Company&#x2019;s Current Report on Form 8-K, as filed with the SEC on February 27, 2026, as well as the Company&#x2019;s Annual Report on Form 10-K for the period ended December 31, 2025, as filed with the SEC on March 27, 2026. The interim results for the three months ended March 31, 2026, are not necessarily indicative of the results to be expected for the period ending December 31, 2026 or for any future periods.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Emerging Growth Company&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The preparation of the unaudited condensed financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,324,398 and $&lt;span style="-sec-ix-hidden:fc_1787106116"&gt;0&lt;/span&gt; in cash as of March 31, 2026 and December 31, 2025, respectively, and no cash equivalents. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; As of March 31, 2026 and December 31, 2025, the assets held in the Trust Account amounted to $230,828,386 and $&lt;span style="-sec-ix-hidden:fc_1408171859"&gt;0&lt;/span&gt;, respectively. As of March 31, 2026, the assets held in the Trust Account are held in money market funds which are invested primarily in U.S. treasury securities. Investments in money market funds are presented on the accompanying condensed balance sheets at fair value at the end of each reporting period. Interest and dividends earned from investments in these securities are included in the accompanying unaudited condensed statement of operations. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Offering Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with the requirements of the FASB ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin Topic&#160;5A, &#x201c;Expenses of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units&#160;between Class&#160;A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants included in the Units&#160;and then to the Class&#160;A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity. Offering costs allocated to the Public Warrants and the Private Placement Units&#160;were charged to shareholders&#x2019; deficit as the underlying financial instruments, after management&#x2019;s evaluation, were classified within shareholders&#x2019; deficit.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;sup&gt;&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximate the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for warrants; see Note 8 for more information.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Income Taxes&lt;sup&gt;&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes under FASB ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; FASB ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_840869526"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_1510133105"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is considered to be a Cayman Islands exempted company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The U.S. federal income tax consequences of a potential redemption of Class A ordinary shares are discussed in Item IA. Risk Factors of the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on March 27, 2026.&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for share awards in accordance with FASB ASC Topic 718, &#x201c;Compensation&#x2014;Stock Compensation,&#x201d; which requires that all equity awards be accounted for at their &#x201c;fair value.&#x201d; Fair value is measured on the grant date and is equal to the underlying value of the share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (e.g., the occurrence of Initial Public Offering). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company&#x2019;s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Warrant Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their relative fair values.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and then to accumulated deficit. Accordingly, as of March 31, 2026, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s condensed balance sheet. As of March 31, 2026, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheet are reconciled in the following table: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;230,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(2,568,333&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(13,146,312&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of Class A ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,543,031&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left; padding-bottom: 4pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;230,828,386&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Net Income per Ordinary Share&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and disclosure requirements of ASC 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average ordinary shares outstanding for the respective period. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. Diluted net income per share attributable to ordinary shareholders adjusts the basic net income per share attributable to ordinary shareholders and the weighted-average ordinary shares outstanding for the potentially dilutive impact of outstanding warrants. However, because the warrants are anti-dilutive, they have been excluded from the calculation of diluted income per ordinary share for the period presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Founder shares issued to the Sponsor were subject to forfeiture contingent upon the exercise of the underwriters&#x2019; over-allotment option. For purposes of diluted income per ordinary share, the founder shares are included in the denominator as of the beginning of the interim period in which the contingent condition was satisfied. Accordingly, the founder shares are included in the calculation of diluted earnings per share as if outstanding from the beginning of the interim period upon the full exercise of the over-allotment option on February 20, 2026.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reflects the calculation of basic and diluted net income per ordinary share:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Three Months Ended&lt;br/&gt; March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Basic&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Diluted&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class A&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class B&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class A&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class B&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic and diluted net income per ordinary share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 52%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;322,841&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;223,238&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;312,641&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;233,438&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-indent: -8.1pt; padding-left: 8.1pt"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,267,833&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,100,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,267,833&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,666,667&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Basic and diluted net income per ordinary share&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_373897767" id="ixv-1725">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). Certain information or footnote disclosures normally included in  financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s prospectus for its Initial Public Offering as filed with the SEC on February 19, 2026, the Company&#x2019;s Current Report on Form 8-K, as filed with the SEC on February 27, 2026, as well as the Company&#x2019;s Annual Report on Form 10-K for the period ended December 31, 2025, as filed with the SEC on March 27, 2026. The interim results for the three months ended March 31, 2026, are not necessarily indicative of the results to be expected for the period ending December 31, 2026 or for any future periods.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <aacou:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="cref_373897767" id="ixv-1735">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Emerging Growth Company&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</aacou:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_373897767" id="ixv-1745">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The preparation of the unaudited condensed financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_373897767" id="ixv-1781">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,324,398 and $&lt;span style="-sec-ix-hidden:fc_1787106116"&gt;0&lt;/span&gt; in cash as of March 31, 2026 and December 31, 2025, respectively, and no cash equivalents. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3981"
      unitRef="uref_1548609138">1324398</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <aacou:InvestmentsHeldInTrustAccountPolicyTextBlock contextRef="cref_373897767" id="ixv-1789">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; As of March 31, 2026 and December 31, 2025, the assets held in the Trust Account amounted to $230,828,386 and $&lt;span style="-sec-ix-hidden:fc_1408171859"&gt;0&lt;/span&gt;, respectively. As of March 31, 2026, the assets held in the Trust Account are held in money market funds which are invested primarily in U.S. treasury securities. Investments in money market funds are presented on the accompanying condensed balance sheets at fair value at the end of each reporting period. Interest and dividends earned from investments in these securities are included in the accompanying unaudited condensed statement of operations. &lt;/p&gt;</aacou:InvestmentsHeldInTrustAccountPolicyTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3982"
      unitRef="uref_1548609138">230828386</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_373897767" id="ixv-1797">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-3983"
      unitRef="uref_1548609138">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="cref_373897767" id="ixv-1803">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Offering Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with the requirements of the FASB ASC&#160;340-10-S99 and SEC Staff Accounting Bulletin Topic&#160;5A, &#x201c;Expenses of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC&#160;470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units&#160;between Class&#160;A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants included in the Units&#160;and then to the Class&#160;A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity. Offering costs allocated to the Public Warrants and the Private Placement Units&#160;were charged to shareholders&#x2019; deficit as the underlying financial instruments, after management&#x2019;s evaluation, were classified within shareholders&#x2019; deficit.&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_373897767" id="ixv-1810">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;sup&gt;&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximate the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature, except for warrants; see Note 8 for more information.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_373897767" id="ixv-1818">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Income Taxes&lt;sup&gt;&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes under FASB ASC Topic&#160;740, &#x201c;Income Taxes,&#x201d; which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; FASB ASC Topic&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_840869526"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_1510133105"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is considered to be a Cayman Islands exempted company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The U.S. federal income tax consequences of a potential redemption of Class A ordinary shares are discussed in Item IA. Risk Factors of the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on March 27, 2026.&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="cref_373897767" id="ixv-1836">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for share awards in accordance with FASB ASC Topic 718, &#x201c;Compensation&#x2014;Stock Compensation,&#x201d; which requires that all equity awards be accounted for at their &#x201c;fair value.&#x201d; Fair value is measured on the grant date and is equal to the underlying value of the share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, in the period of grant for awards that vest immediately and have no future service condition, or in the period the awards vest immediately after meeting a performance condition becomes probable (e.g., the occurrence of Initial Public Offering). For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company&#x2019;s initial estimates; previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <aacou:WarrantInstrumentsPolicyTextBlock contextRef="cref_373897767" id="ixv-1864">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Warrant Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their relative fair values.&lt;/p&gt;</aacou:WarrantInstrumentsPolicyTextBlock>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="cref_373897767" id="ixv-1871">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and then to accumulated deficit. Accordingly, as of March 31, 2026, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s condensed balance sheet. As of March 31, 2026, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheet are reconciled in the following table: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;230,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(2,568,333&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(13,146,312&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of Class A ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,543,031&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left; padding-bottom: 4pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;230,828,386&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="cref_373897767" id="ixv-3984">As of March 31, 2026, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheet are reconciled in the following table:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;230,000,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(2,568,333&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Public Shares issuance costs&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(13,146,312&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accretion of Class A ordinary shares to redemption amount&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,543,031&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left; padding-bottom: 4pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;230,828,386&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3985"
      unitRef="uref_1548609138">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3986"
      unitRef="uref_1548609138">2568333</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3987"
      unitRef="uref_1548609138">-13146312</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3988"
      unitRef="uref_1548609138">16543031</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-3989"
      unitRef="uref_1548609138">230828386</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_373897767" id="ixv-1924">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Net Income per Ordinary Share&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and disclosure requirements of ASC 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average ordinary shares outstanding for the respective period. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value. Diluted net income per share attributable to ordinary shareholders adjusts the basic net income per share attributable to ordinary shareholders and the weighted-average ordinary shares outstanding for the potentially dilutive impact of outstanding warrants. However, because the warrants are anti-dilutive, they have been excluded from the calculation of diluted income per ordinary share for the period presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Founder shares issued to the Sponsor were subject to forfeiture contingent upon the exercise of the underwriters&#x2019; over-allotment option. For purposes of diluted income per ordinary share, the founder shares are included in the denominator as of the beginning of the interim period in which the contingent condition was satisfied. Accordingly, the founder shares are included in the calculation of diluted earnings per share as if outstanding from the beginning of the interim period upon the full exercise of the over-allotment option on February 20, 2026.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reflects the calculation of basic and diluted net income per ordinary share:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Three Months Ended&lt;br/&gt; March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Basic&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Diluted&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class A&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class B&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class A&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class B&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic and diluted net income per ordinary share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 52%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;322,841&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;223,238&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;312,641&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;233,438&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-indent: -8.1pt; padding-left: 8.1pt"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,267,833&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,100,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,267,833&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,666,667&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Basic and diluted net income per ordinary share&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_373897767" id="ixv-1953">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reflects the calculation of basic and diluted net income per ordinary share:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&#160;Three Months Ended&lt;br/&gt; March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Basic&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Diluted&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class A&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class B&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class A&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class B&lt;br/&gt; Ordinary Shares&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic and diluted net income per ordinary share:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 52%; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Allocation of net income&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;322,841&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;223,238&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;312,641&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;233,438&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-indent: -8.1pt; padding-left: 8.1pt"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Weighted-average shares outstanding&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,267,833&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,100,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,267,833&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,666,667&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Basic and diluted net income per ordinary share&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.03&lt;/td&gt; &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3990"
      unitRef="uref_1548609138">322841</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_889495524"
      decimals="0"
      id="ixv-3991"
      unitRef="uref_1548609138">223238</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3992"
      unitRef="uref_1548609138">312641</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_889495524"
      decimals="0"
      id="ixv-3993"
      unitRef="uref_1548609138">233438</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3994"
      unitRef="uref_1714581825">10267833</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_889495524"
      decimals="0"
      id="ixv-3995"
      unitRef="uref_1714581825">7100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1513325083"
      decimals="0"
      id="ixv-3996"
      unitRef="uref_1714581825">10267833</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_889495524"
      decimals="0"
      id="ixv-3997"
      unitRef="uref_1714581825">7666667</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1513325083"
      decimals="2"
      id="ixv-3998"
      unitRef="uref_1737341840">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_889495524"
      decimals="2"
      id="ixv-3999"
      unitRef="uref_1737341840">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1513325083"
      decimals="2"
      id="ixv-4000"
      unitRef="uref_1737341840">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_889495524"
      decimals="2"
      id="ixv-4001"
      unitRef="uref_1737341840">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_373897767" id="ixv-2091">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <aacou:InitialPublicOfferingTextBlock contextRef="cref_373897767" id="ixv-2098">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;3 &#x2014;&#160;Initial Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Pursuant to the closing of the Initial Public Offering, the Company sold 23,000,000&#160;Units at a purchase price of $10.00 per Unit. Each Unit has a price of $10.00 and consists of one Class&#160;A ordinary share, and one-third of one redeemable Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share, subject to adjustment. Each Public Warrant will become exercisable 30&#160;days after the completion of the initial Business Combination and will expire five&#160;years after the completion of the initial Business Combination, or earlier upon redemption or liquidation. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; &lt;span style="font-weight: bold;"&gt;Warrants&#160;&#x2014;&lt;/span&gt;&#160;There are 7,666,667 Public Warrants and 231,667 Private Warrants currently outstanding. Each whole Warrant entitles the holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. The Warrants cannot be exercised until 30&#160;days after the completion of the initial Business Combination, and will expire at 5:00&#160;p.m., New&#160;York City time, five&#160;years after the completion of the initial Business Combination or earlier upon redemption or liquidation. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company will not be obligated to deliver any Class&#160;A ordinary shares pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise unless a registration statement on Form S-1, Form S-3, Form F-1, or Form F-3, as applicable, under the Securities Act with respect to the Class&#160;A ordinary shares underlying the Warrants is then effective and a prospectus relating thereto is current. No Warrant will be exercisable and the Company will not be obligated to issue a Class&#160;A ordinary share upon exercise of a Warrant unless the Class&#160;A ordinary share issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant will not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any Warrant. In the event that a registration statement on Form S-1, Form S-3, Form F-1, or Form F-3, as applicable, is not effective for the exercised Warrants, the purchaser of a Unit containing such Warrant will have paid the full purchase price for the Unit solely for the Class&#160;A ordinary share underlying such Unit.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Under the terms of the warrant agreement, the Company will agree that, as soon as practicable, but in no event later than 20&#160;business days after the closing of its Business Combination, it will use commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the Initial Public Offering or a new registration statement on Form S-1, Form S-3, Form F-1, or Form F-3, as applicable, covering the registration under the Securities Act&#160;of&#160;the Class&#160;A ordinary shares issuable upon exercise of the Warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60&#160;business days following the Company&#x2019;s initial Business Combination and to maintain a current prospectus relating to the Class&#160;A ordinary shares issuable upon exercise of the Warrants until the expiration of the Warrants in accordance with the provisions of the warrant agreement. If a registration statement on Form S-1, Form S-3, Form F-1, or Form F-3, as applicable, covering the Class&#160;A ordinary shares issuable upon exercise of the Warrants is not effective by the sixtieth (60&lt;sup&gt;th&lt;/sup&gt;) business&#160;day after the closing of the initial Business Combination, Warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act or another exemption. Notwithstanding the above, if the Class&#160;A ordinary shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section&#160;18(b)(1)&#160;of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the holders exercise their Public Warrants on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A ordinary shares underlying the warrants, multiplied by the excess of the &#x201c;fair market value&#x201d; of the Class&#160;A ordinary shares over the exercise price of the warrants by (y)&#160;the fair market value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt; The &#x201c;fair market value&#x201d; is the average reported closing price of the Class&#160;A ordinary shares for the 10&#160;trading days ending on the third&#160;trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; &lt;i&gt;Redemption of Warrants When the Price per Class&#160;A Ordinary Share Equals or Exceeds $18.00&lt;/i&gt;: The Company may redeem the outstanding Warrants: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-indent: -19.45pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.25in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-indent: -19.45pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.25in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at a price of $0.01 per Warrant;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-indent: -19.45pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.25in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon a minimum of 30&#160;days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption period&#x201d;); and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.85pt; text-indent: -19.45pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.25in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if, and only if, the closing price of the Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Warrant) for any 20&#160;trading days within a 30-trading&#160;day period commencing at least 30&#160;days after completion of the Company&#x2019;s initial Business Combination and ending three&#160;business days before the Company sends the notice of redemption to the Warrant holders.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Additionally, if the number of outstanding Class&#160;A ordinary shares is increased by a share capitalization payable in Class&#160;A ordinary shares, or by a subdivision of ordinary shares or other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number of Class&#160;A ordinary shares issuable on exercise of each Warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class&#160;A ordinary shares at a price less than the fair market value will be deemed a share capitalization of a number of Class&#160;A ordinary shares equal to the product of (i)&#160;the number of Class&#160;A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class&#160;A ordinary shares) and (ii)&#160;the quotient of (x)&#160;the price per Class&#160;A ordinary share paid in such rights offering and (y)&#160;the fair market value. For these purposes (i)&#160;if the rights offering is for securities convertible into or exercisable for Class&#160;A ordinary shares, in determining the price payable for Class&#160;A ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii)&#160;fair market value means the volume weighted average price of Class&#160;A ordinary shares as reported during the ten (10)&#160;trading&#160;day period ending on the&#160;trading day prior to the first date on which the Class&#160;A ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. &lt;/p&gt;</aacou:InitialPublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_694894069"
      decimals="0"
      id="ixv-4002"
      unitRef="uref_1714581825">23000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1489176576"
      decimals="2"
      id="fc_2037189353"
      unitRef="uref_1737341840">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1271755796"
      decimals="2"
      id="fc_1121921114"
      unitRef="uref_1737341840">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_586599417"
      decimals="2"
      id="fc_586599417"
      unitRef="uref_1737341840">11.5</us-gaap:SharesIssuedPricePerShare>
    <aacou:NumberOfDaysAfterCompletionInitialBusinessCombination contextRef="cref_694894069" id="ixv-4006">P30D</aacou:NumberOfDaysAfterCompletionInitialBusinessCombination>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_562520141"
      decimals="0"
      id="ixv-4007"
      unitRef="uref_1714581825">7666667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1258609701"
      decimals="0"
      id="ixv-4008"
      unitRef="uref_1714581825">231667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_158500031"
      decimals="2"
      id="fc_158500031"
      unitRef="uref_1737341840">11.5</us-gaap:SharesIssuedPricePerShare>
    <aacou:NumberOfDaysAfterCompletionInitialBusinessCombination contextRef="cref_1581599079" id="ixv-4010">P30D</aacou:NumberOfDaysAfterCompletionInitialBusinessCombination>
    <aacou:PeriodToFileRegistrationStatementAfterInitialBusinessCombination contextRef="cref_373897767" id="ixv-4011">P20D</aacou:PeriodToFileRegistrationStatementAfterInitialBusinessCombination>
    <aacou:PeriodForRegistrationStatementToBecomeEffective contextRef="cref_373897767" id="ixv-4012">P60D</aacou:PeriodForRegistrationStatementToBecomeEffective>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays contextRef="cref_1513325083" id="ixv-4013">P10D</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1271755796"
      decimals="2"
      id="fc_351261606"
      unitRef="uref_1737341840">18</us-gaap:SharesIssuedPricePerShare>
    <aacou:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRight
      contextRef="cref_373897767"
      decimals="2"
      id="ixv-4015"
      unitRef="uref_1737341840">0.01</aacou:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRight>
    <aacou:PriorWrittenNoticeOfRedemption contextRef="cref_373897767" id="ixv-4016">P30D</aacou:PriorWrittenNoticeOfRedemption>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="cref_373897767" id="ixv-4017">P30D</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightStockPriceTrigger
      contextRef="cref_373897767"
      decimals="2"
      id="ixv-4018"
      unitRef="uref_1737341840">18</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightStockPriceTrigger>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays contextRef="cref_373897767" id="ixv-4019">P20D</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="cref_373897767" id="ixv-4020">P30D</aacou:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <aacou:ExercisableAfterTheCompletionOfTheInitialBusinessCombination contextRef="cref_373897767" id="ixv-4021">P30D</aacou:ExercisableAfterTheCompletionOfTheInitialBusinessCombination>
    <aacou:TradingDays contextRef="cref_373897767" id="ixv-4022">P10D</aacou:TradingDays>
    <aacou:PrivatePlacementTextBlock contextRef="cref_373897767" id="ixv-2180">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;4 &#x2014;&#160;Private Placement&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Simultaneously with the closing of the Initial Public Offering, the Sponsor and the underwriters purchased an aggregate of 695,000 Private Placement Units, at a price of $10.00 per Private Placement Unit, or $6,950,000. Of those 695,000 Private Placement Units, the Sponsor purchased 465,000 Private Placement Units and BTIG, LLC purchased 230,000 Private Placement Units. Each Private Placement Unit consists of one Class&#160;A ordinary share and one-third of one redeemable warrant. Each whole Private Placement Warrant entitles the registered holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share, subject to adjustment. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering except that, so long as they are held by the Sponsor, BTIG, LLC, or their permitted transferees, the Private Placement Warrants (i)&#160;may not (including the Class&#160;A ordinary shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30&#160;days after the completion of the initial Business Combination, (ii)&#160;will be entitled to registration rights and (iii)&#160;with respect to Private Placement Warrants held by BTIG, LLC and/or its designees, will not be exercisable more than five&#160;years from the commencement of sales in the Initial Public Offering in accordance with Financial Industry Regulatory Authority  Rule&#160;5110(g)(8). &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Sponsor, officers and directors entered into a letter agreement with the Company, pursuant to which they will agree to (i)&#160;waive their redemption rights with respect to any shares held by them in connection with the completion of the initial Business Combination; (ii)&#160;waive their redemption rights with respect to any shares held by them in connection with a shareholder vote to approve an amendment to the amended and restated memorandum and articles of association (A)&#160;to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Completion Window or (B)&#160;with respect to any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity; (iii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and Private Placement Shares if the Company fails to complete an initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete an initial Business Combination within the prescribed time frame and to liquidating distributions from assets outside the Trust Account; and (iv)&#160;vote any founder shares and Private Placement Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions, aside from shares they may purchase in compliance with the requirements of Rule&#160;14e-5 under the Exchange&#160;Act, which would not be voted in favor of approving the Business Combination transaction) in favor of the initial Business Combination. &lt;/p&gt;</aacou:PrivatePlacementTextBlock>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1995627856"
      decimals="0"
      id="ixv-4023"
      unitRef="uref_1714581825">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1670301127"
      decimals="2"
      id="fc_1026869593"
      unitRef="uref_1737341840">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_475759915"
      decimals="0"
      id="ixv-4025"
      unitRef="uref_1548609138">6950000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_105683079"
      decimals="0"
      id="ixv-4026"
      unitRef="uref_1714581825">695000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1670301127"
      decimals="0"
      id="ixv-4027"
      unitRef="uref_1714581825">465000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <aacou:UnitsIssuedDuringPeriodUnitsIssued
      contextRef="cref_1630215272"
      decimals="0"
      id="ixv-4028"
      unitRef="uref_1714581825">230000</aacou:UnitsIssuedDuringPeriodUnitsIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_105683079"
      decimals="2"
      id="fc_105683079"
      unitRef="uref_1737341840">11.5</us-gaap:SharesIssuedPricePerShare>
    <aacou:NumberOfDaysAfterCompletionOfInitialBusinessCombination contextRef="cref_373897767" id="ixv-4030">P30D</aacou:NumberOfDaysAfterCompletionOfInitialBusinessCombination>
    <aacou:PercentageRedeemablePublicShares
      contextRef="cref_373897767"
      decimals="2"
      id="ixv-4031"
      unitRef="uref_78808507">1</aacou:PercentageRedeemablePublicShares>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_373897767" id="ixv-2210">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;5 &#x2014;&#160;Related Party Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Founder Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; On November&#160;28, 2025, the Initial Shareholders made capital contributions of $25,000 in the aggregate, or approximately $0.003 per share, to cover certain of the Company&#x2019;s expenses, for which the Company issued 5,750,000 founder shares to the Initial Shareholders. On December 16,&#160;2025, the Company issued additional 1,916,667 founder shares through a share capitalization resulting in the Sponsor holding 7,666,667 founder shares in the aggregate. All share and per-share data have been retrospectively presented. Up to 1,000,000 of the founder shares may be surrendered by the Sponsor for no consideration depending on the extent to which the underwriters&#x2019; over-allotment option is exercised. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option on February 2, 2026, 1,000,000 founder shares are no longer subject to forfeiture by the Sponsor. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; On January 26, 2026, the Sponsor granted membership interest equivalent to the aggregate of 175,000 founder shares to independent directors and an officer. All granted membership interests are in exchange for their services as directors and officer through the Company&#x2019;s initial Business Combination. The transfer of founder shares to the independent directors and officer is in the scope of FASB ASC Topic 718, &#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under ASC 718, stock-based compensation associated with equity classified awards is measured at fair value upon the assignment date. The total fair value of the 175,000 founder shares equivalents granted to the directors and officer was $459,550 or approximately $2.63 per share. The Company established the initial fair value founder shares on January 26, 2026, using a calculation prepared by a third party valuation team which takes into consideration the implied share price of $9.88 and probability of de-SPAC and instrument-specific market adjustment of 26.6%. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of founder shares that ultimately vest times the assignment date fair value per share (unless subsequently modified) less the amount initially received for the transfer of founder shares. As of March 31, 2026, the Company determined that the initial Business Combination is not considered probable and therefore no compensation expense has been recognized. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company&#x2019;s Initial Shareholders have agreed not to transfer, assign or sell any of their founder shares and any Class&#160;A ordinary shares issued upon conversion thereof until the earlier to occur of (i)&#160;six months after the completion of the initial Business Combination or (ii)&#160;the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company&#x2019;s shareholders having the right to exchange their Class&#160;A ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company&#x2019;s Initial Shareholders with respect to any founder shares (the &#x201c;Lock-up&#x201d;). Notwithstanding the foregoing, if (1)&#160;the closing price of the Class&#160;A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20&#160;trading days within any 30-trading&#160;day period commencing at least 30&#160;days after the initial Business Combination or (2)&#160;if the Company consummates a transaction after the initial Business Combination which results in the Company&#x2019;s shareholders having the right to exchange their shares for cash, securities or other property, the founder shares will be released from the Lock-up. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Promissory Note&#160;&#x2014;&#160;Related Party&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Sponsor has agreed to loan the Company an aggregate of up to $400,000 to be used for a portion of the expenses of the Initial Public Offering (the &#x201c;Promissory Note&#x201d;). The Promissory Note is non-interest bearing, unsecured and due at the earlier of (i)&#160;October&#160;31, 2026 or (ii)&#160;the closing of the Initial Public Offering. As of February 20, 2026, there was $302,954 outstanding under the Promissory Note, which was fully settled simultaneously with the closing of the Initial Public Offering. Borrowings under the Promissory Note are no longer available. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Reimbursements to Officers&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; For the three months ended March 31, 2026, the Company has incurred $37,450 for the services of the Chief Financial Officer and Chief Executive Officer, reimbursable office and travel expenses, and for office space and administrative support. These expenses are included in formation, general and administrative costs on the unaudited condensed statement of operations. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Administrative Services Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Commencing on the effective date of the securities of the Company are first listed, February 18, 2026, the Company entered into an agreement with an affiliate of the Sponsor to pay an aggregate of $25,000 per month for the services of the Chief Financial Officer and Chief Operating Officer, and for office space and administrative support. Upon completion of the initial Business Combination or the liquidation, the Company will cease paying the $25,000 per month fee. For the three months ended March 31, 2026, the Company incurred and paid $50,000 in fees for these services. These expenses are included in formation, general and administrative costs on the unaudited condensed statement of operations. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Related Party Loans&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 8.5pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company Working Capital Loans as may be required on a non-interest basis. If the Company completes an initial Business Combination, the Company would repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use amounts held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units of the post-Business Combination entity at a price of $10.00 per unit at the option of the lender. Such units would be identical to the Private Placement Units. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. As of March 31, 2026 and December 31, 2025, &lt;span style="-sec-ix-hidden:fc_1127746005"&gt;no&lt;/span&gt; such Working Capital Loans were outstanding. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_21244380"
      decimals="0"
      id="ixv-4032"
      unitRef="uref_1548609138">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1413226857"
      decimals="3"
      id="ixv-4033"
      unitRef="uref_1737341840">0.003</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_749400756"
      decimals="0"
      id="ixv-4034"
      unitRef="uref_1714581825">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_984596877"
      decimals="0"
      id="ixv-4035"
      unitRef="uref_1714581825">1916667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_492339568"
      decimals="0"
      id="ixv-4036"
      unitRef="uref_1714581825">7666667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_245660575"
      decimals="0"
      id="ixv-4037"
      unitRef="uref_1714581825">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_1716804700"
      decimals="0"
      id="ixv-4038"
      unitRef="uref_1714581825">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1955056443"
      decimals="0"
      id="ixv-4039"
      unitRef="uref_1714581825">175000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="cref_1164959796"
      decimals="0"
      id="ixv-4040"
      unitRef="uref_1714581825">175000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="cref_1164959796"
      decimals="0"
      id="ixv-4041"
      unitRef="uref_1548609138">459550</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_287193436"
      decimals="2"
      id="ixv-4042"
      unitRef="uref_1737341840">2.63</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1494685565"
      decimals="2"
      id="ixv-4043"
      unitRef="uref_1737341840">9.88</us-gaap:SharesIssuedPricePerShare>
    <aacou:PercentageOfMarketAdjustment
      contextRef="cref_1955056443"
      decimals="3"
      id="ixv-4044"
      unitRef="uref_78808507">0.266</aacou:PercentageOfMarketAdjustment>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1815466083"
      decimals="2"
      id="ixv-4045"
      unitRef="uref_1737341840">12</us-gaap:SharesIssuedPricePerShare>
    <aacou:NumberOfTradingDaysOfBusinessCombination contextRef="cref_1888092448" id="ixv-4046">P20D</aacou:NumberOfTradingDaysOfBusinessCombination>
    <aacou:NumberOfTradingDaysOfBusinessCombination contextRef="cref_1826633313" id="ixv-4047">P30D</aacou:NumberOfTradingDaysOfBusinessCombination>
    <us-gaap:OtherExpenses
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-4048"
      unitRef="uref_1548609138">400000</us-gaap:OtherExpenses>
    <us-gaap:NotesPayableCurrent
      contextRef="cref_2093904440"
      decimals="0"
      id="ixv-4049"
      unitRef="uref_1548609138">302954</us-gaap:NotesPayableCurrent>
    <aacou:ReimbursableOfficeExpenses
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-4050"
      unitRef="uref_1548609138">37450</aacou:ReimbursableOfficeExpenses>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1571238291"
      decimals="0"
      id="ixv-4051"
      unitRef="uref_1548609138">25000</us-gaap:AdministrativeFeesExpense>
    <aacou:AggregateSponsorAmount
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-4052"
      unitRef="uref_1548609138">25000</aacou:AggregateSponsorAmount>
    <us-gaap:PaymentsForFees
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-4053"
      unitRef="uref_1548609138">50000</us-gaap:PaymentsForFees>
    <aacou:WorkingCapitalLoans
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-4054"
      unitRef="uref_1548609138">1500000</aacou:WorkingCapitalLoans>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="cref_1666238458"
      decimals="2"
      id="fc_1666238458"
      unitRef="uref_1737341840">10</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_373897767" id="ixv-2270">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;6 &#x2014;&#160;Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the military escalations between the United States and Iran, the ongoing Russia-Ukraine conflict and other similar geopolitical conflicts. Ongoing military escalation between the United States and Iran has heightened risks to critical infrastructure, shipping routes, and energy supplies. Any further deterioration could drive sustained increases in oil prices, disrupt global trade, contribute to macroeconomic instability, and materially height the risk of a global recession. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (&#x201c;NATO&#x201d;) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act. FASB ASC 740, &#x201c;Income Taxes&#x201d;, requires the effects of changes in tax laws to be recognized in the period in which the legislation is enacted. The Company is currently evaluating the impact of the new law. However, none of the tax provisions are expected to have a significant impact on the Company&#x2019;s unaudited condensed financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from these geopolitical conditions could reduce the pool of viable attractive target candidates for an initial Business Combination, the Russian invasion of Ukraine, the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company&#x2019;s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Registration Rights&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The holders of the (i)&#160;founder shares, which were issued in a private placement prior to the closing of the Initial Public Offering, (ii)&#160;Private Placement Units&#160;(and the securities comprising such units and the Class&#160;A ordinary shares issuable upon exercise of the Private Placement Warrants) which were issued in a private placement simultaneously with the closing of the Initial Public Offering and (iii)&#160;Private Placement Units&#160;(and the securities comprising such units and the Class&#160;A ordinary shares issuable upon exercise of the Private Placement Warrants) that may be issued upon conversion of Working Capital Loans have registration rights to require the Company to register a sale of any of the Company&#x2019;s securities held by them and any other securities of the Company acquired by them prior to the consummation of an initial Business Combination pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#x201c;piggyback&#x201d; registration rights with respect to registration statements filed subsequent to the completion of an initial Business Combination. Notwithstanding anything to the contrary, BTIG, LLC may only make a demand on one occasion and only during the five-year period beginning on the effective date of the registration statement relating to the Company&#x2019;s Initial Public Offering. In addition, BTIG, LLC may participate in a &#x201c;piggyback&#x201d; registration only during the seven-year period beginning on the effective date of the registration statement relating to the Company&#x2019;s Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Underwriting Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,000,000&#160;units to cover over-allotments, if any. On February 20, 2026, the underwriters exercised their over-allotment option, closing on the 3,000,000 additional Units simultaneously with the Initial Public Offering. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The underwriters were paid a cash underwriting discount of 2.00% of the gross proceeds of the units offered in the Initial Public Offering, or $4,600,000 upon the closing of the Initial Public Offering. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Additionally, the underwriters are entitled to a deferred underwriting discount of 3.50% of the gross proceeds of the Initial Public Offering held in the Trust Account, $8,050,000, payable to BTIG, LLC to be deposited in the Trust Account and released to BTIG, LLC only upon the completion of an initial Business Combination. The deferred underwriting commissions are payable as follows: (i)&#160;$0.20 per Unit sold in the Initial Public Offering is paid to BTIG, LLC in cash upon the closing of the initial Business Combination and (ii)&#160;$0.15 per Unit sold in the Initial Public Offering is payable to BTIG, LLC in cash, based on the funds remaining in the Trust Account after giving effect to public shares that are redeemed in connection with an initial Business Combination. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <aacou:UnderwritersOptionPeriodFromDateOfProposedPublicOffering contextRef="cref_694894069" id="ixv-4056">P45D</aacou:UnderwritersOptionPeriodFromDateOfProposedPublicOffering>
    <aacou:UnitsIssuedDuringPeriodSharesNewISsues
      contextRef="cref_201454176"
      decimals="0"
      id="ixv-4057"
      unitRef="uref_1714581825">3000000</aacou:UnitsIssuedDuringPeriodSharesNewISsues>
    <aacou:UnderwritersPartiallyExercisedOverAllotmentOption
      contextRef="cref_40338982"
      decimals="0"
      id="ixv-4058"
      unitRef="uref_1714581825">3000000</aacou:UnderwritersPartiallyExercisedOverAllotmentOption>
    <aacou:UnderwritingDiscountPercentage
      contextRef="cref_373897767"
      decimals="4"
      id="ixv-4059"
      unitRef="uref_78808507">0.02</aacou:UnderwritingDiscountPercentage>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_694894069"
      decimals="0"
      id="fc_694894069"
      unitRef="uref_1548609138">4600000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <aacou:DeferredUnderwritingDiscountRate
      contextRef="cref_373897767"
      decimals="4"
      id="ixv-4061"
      unitRef="uref_78808507">0.035</aacou:DeferredUnderwritingDiscountRate>
    <aacou:TrustAccountPayable
      contextRef="cref_475799433"
      decimals="0"
      id="ixv-4062"
      unitRef="uref_1548609138">8050000</aacou:TrustAccountPayable>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1875495703"
      decimals="2"
      id="ixv-4063"
      unitRef="uref_1737341840">0.2</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_697426530"
      decimals="2"
      id="ixv-4064"
      unitRef="uref_1737341840">0.15</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_373897767" id="ixv-2321">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;7 &#x2014;&#160;Shareholders&#x2019; Deficit&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preference Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue a total of 5,000,000 preference shares at par value of $0.0001 each. At March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1140432218"&gt;&lt;span style="-sec-ix-hidden:fc_1992290329"&gt;no&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;A Ordinary Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue a total of 500,000,000 Class&#160;A ordinary shares at par value of $0.0001 each. At March 31, 2026, there were 695,000 of Class&#160;A ordinary shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption). At December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_783149177"&gt;&lt;span style="-sec-ix-hidden:fc_1676091037"&gt;no&lt;/span&gt;&lt;/span&gt; Class&#160;A ordinary shares issued and outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; &lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;B Ordinary Shares&lt;/i&gt;&lt;/span&gt;&#160;&#x2014;&#160;The Company is authorized to issue a total of 50,000,000 Class&#160;B ordinary shares at par value of $0.0001 each. At March 31, 2026 and December 31, 2025, there were 7,666,667 Class&#160;B ordinary shares issued and outstanding, of which an aggregate of up to 1,000,000 Class&#160;B ordinary shares are subject to forfeiture if the over-allotment option is not exercised by the underwriters in full. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option on February 20, 2026, 1,000,000 founder shares are no longer subject to forfeiture by the Sponsor. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The founder shares will automatically convert into Class&#160;A ordinary shares (which such Class&#160;A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions from the Trust Account if the Company fails to consummate an initial Business Combination) concurrently with or immediately following the consummation of an initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class&#160;A ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class&#160;B ordinary shares convert into Class&#160;A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class&#160;B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class&#160;A ordinary shares issuable upon conversion of all Class&#160;B ordinary shares will equal, in the aggregate, 25% of the sum of (i)&#160;the total number of all Class&#160;A ordinary shares outstanding upon the completion of the Initial Public Offering (including any Class&#160;A ordinary shares issued pursuant to the underwriters&#x2019; over-allotment option and excluding the Class&#160;A ordinary shares comprising part of the Private Placement Units&#160;and the Class&#160;A ordinary shares underlying the Private Placement Warrants), plus (ii)&#160;all Class&#160;A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent units issued to the Sponsor or any of its affiliates or to the Company&#x2019;s officers or directors upon conversion of Working Capital Loans) minus (iii)&#160;any redemptions of Class&#160;A ordinary shares by public shareholders in connection with an initial Business Combination and any Class&#160;A ordinary shares redeemed by public shareholders in connection with any amendment to the amended and restated memorandum and articles of association made prior to the consummation of the initial Business Combination (A)&#160;to modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete an initial Business Combination within the completion window or (B)&#160;with respect to any other material provisions relating to the rights of holders of Class&#160;A ordinary shares or pre-business combination activity; provided that such conversion of founder shares will never occur on a less than one-for-one basis. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Holders of record of the Company&#x2019;s Class&#160;A ordinary shares and Class&#160;B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the Company&#x2019;s amended and restated memorandum and articles of association or as required by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law and the Company&#x2019;s amended and restated memorandum and articles of association, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by the Company&#x2019;s shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the Company&#x2019;s amended and restated memorandum and articles of association, such actions include amending the Company&#x2019;s amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; There is no cumulative voting with respect to the appointment of directors, meaning, following the Company&#x2019;s initial Business Combination, the holders of more than 50% of the Company&#x2019;s ordinary shares voted for the appointment of directors can elect all of the directors. Prior to the consummation of an initial Business Combination, only holders of the Company&#x2019;s Class&#160;B ordinary shares will (i)&#160;have the right to vote on the appointment and removal of directors and (ii)&#160;be entitled to vote on continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the Company&#x2019;s constitutional documents or to adopt new constitutional documents, in each case, as a result of approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the Company&#x2019;s Class&#160;A ordinary shares will not be entitled to vote on these matters during such time. These provisions of the Company&#x2019;s amended and restated memorandum and articles of association may only be amended if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of an initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company. &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1433015701"
      decimals="0"
      id="ixv-4065"
      unitRef="uref_1714581825">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_1433015701"
      decimals="4"
      id="ixv-4066"
      unitRef="uref_1737341840">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-4067"
      unitRef="uref_1714581825">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1271755796"
      decimals="4"
      id="ixv-4068"
      unitRef="uref_1737341840">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-4069"
      unitRef="uref_1714581825">695000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-4070"
      unitRef="uref_1714581825">695000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_1271755796"
      decimals="0"
      id="ixv-4071"
      unitRef="uref_1714581825">23000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1084074997"
      decimals="0"
      id="ixv-4072"
      unitRef="uref_1714581825">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1084074997"
      decimals="4"
      id="ixv-4073"
      unitRef="uref_1737341840">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1084074997"
      decimals="0"
      id="ixv-4074"
      unitRef="uref_1714581825">7666667</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1084074997"
      decimals="0"
      id="ixv-4075"
      unitRef="uref_1714581825">7666667</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1192990110"
      decimals="0"
      id="ixv-4076"
      unitRef="uref_1714581825">7666667</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1192990110"
      decimals="0"
      id="ixv-4077"
      unitRef="uref_1714581825">7666667</us-gaap:CommonStockSharesOutstanding>
    <aacou:NumberOfOrdinarySharesSubjectToForfeitureIfTheOverallotmentOptionIsNotExercised
      contextRef="cref_1084074997"
      decimals="0"
      id="ixv-4078"
      unitRef="uref_1714581825">1000000</aacou:NumberOfOrdinarySharesSubjectToForfeitureIfTheOverallotmentOptionIsNotExercised>
    <aacou:NumberOfSharesAreNoLongerSubjectToForfeiture
      contextRef="cref_1714581825"
      decimals="0"
      id="ixv-4079"
      unitRef="uref_1714581825">1000000</aacou:NumberOfSharesAreNoLongerSubjectToForfeiture>
    <aacou:PercentageOfSharesUponConversion
      contextRef="cref_373897767"
      decimals="2"
      id="ixv-4080"
      unitRef="uref_78808507">0.25</aacou:PercentageOfSharesUponConversion>
    <aacou:PercentageOfPublicShares
      contextRef="cref_373897767"
      decimals="2"
      id="ixv-4081"
      unitRef="uref_78808507">1</aacou:PercentageOfPublicShares>
    <aacou:PercentageOfInitialBusinessCombinationHolders
      contextRef="cref_373897767"
      decimals="2"
      id="ixv-4082"
      unitRef="uref_78808507">0.50</aacou:PercentageOfInitialBusinessCombinationHolders>
    <aacou:MinimumPercentageOfVotingInterestsToBeAcquiredInBusinessCombination
      contextRef="cref_373897767"
      decimals="2"
      id="ixv-4083"
      unitRef="uref_78808507">0.90</aacou:MinimumPercentageOfVotingInterestsToBeAcquiredInBusinessCombination>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_373897767" id="ixv-2369">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;8 &#x2014;&#160;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level&#160;1 measurements) and the lowest priority to unobservable inputs (Level&#160;3 measurements). These tiers include:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.25in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: -16.2pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.25in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: -16.2pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;&lt;td style="width: 0.25in"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; At March 31, 2026, assets held in the Trust Account were comprised of $230,828,386 in money market funds which are invested primarily in U.S. Treasury Securities. Through March 31, 2026, the Company did not withdraw interest earned on the Trust Account. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: justify"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 64%; text-align: justify"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 11%; text-align: center"&gt;1&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;230,828,386&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden:fc_1638241348"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The fair value of the Public Warrants issued in the Initial Public Offering is $2,568,333, or approximately $0.34 per Public Warrant. The Public Warrants issued in the Initial Public Offering have been classified within shareholders&#x2019; deficit and will not require remeasurement after issuance. The fair value of the Public Warrants was calculated utilizing a Monte Carlo simulation. The following table presents the quantitative information regarding market assumptions used in the level 3 valuation of the Public Warrants issued in the Initial Public Offering: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;February&#160;20,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: justify"&gt;Remaining term (years)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;7.0&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: justify"&gt;Probability of de-SPAC and instrument-specific market adjustment&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;28.90&lt;/td&gt; &lt;td style="text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: justify"&gt;Risk-free rate (continuous)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3.78&lt;/td&gt; &lt;td style="text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: justify"&gt;Implied Class A share price&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;9.85&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-4084"
      unitRef="uref_1548609138">230828386</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="cref_373897767" id="ixv-2406">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value on a recurring basis at March 31, 2026 and December 31, 2025, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: justify"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 64%; text-align: justify"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 11%; text-align: center"&gt;1&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;230,828,386&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden:fc_1638241348"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1027377133"
      decimals="0"
      id="ixv-4085"
      unitRef="uref_1548609138">230828386</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_617820511"
      decimals="0"
      id="ixv-4086"
      unitRef="uref_1548609138">2568333</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1737341840"
      decimals="2"
      id="ixv-4087"
      unitRef="uref_1737341840">0.34</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock contextRef="cref_373897767" id="ixv-4088">The following table presents the quantitative information regarding market assumptions used in the level 3 valuation of the Public Warrants issued in the Initial Public Offering:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;February&#160;20,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: justify"&gt;Remaining term (years)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;7.0&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: justify"&gt;Probability of de-SPAC and instrument-specific market adjustment&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;28.90&lt;/td&gt; &lt;td style="text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: justify"&gt;Risk-free rate (continuous)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3.78&lt;/td&gt; &lt;td style="text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: justify"&gt;Implied Class A share price&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;9.85&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_846928445"
      decimals="1"
      id="ixv-4089"
      unitRef="uref_78808507">7</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1755592433"
      decimals="4"
      id="ixv-4090"
      unitRef="uref_78808507">0.289</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1244046700"
      decimals="4"
      id="ixv-4091"
      unitRef="uref_78808507">0.0378</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_78808507"
      decimals="2"
      id="ixv-4092"
      unitRef="uref_78808507">9.85</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_373897767" id="ixv-2485">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;9 &#x2014;&#160;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;FASB ASC Topic&#160;280, &#x201c;Segment Reporting&#x201d;, establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), or group, in deciding how to allocate resources and assess performance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company&#x2019;s CODM has been identified as the &lt;span style="-sec-ix-hidden:fc_824299840"&gt;Chief Executive Officer&lt;/span&gt;, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has &lt;span style="-sec-ix-hidden:fc_1509847698"&gt;one&lt;/span&gt; reportable segment. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed statement of operations as net income or loss. The measure of segment assets is reported on the condensed balance sheets as total assets. When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%; text-align: left"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;230,828,386&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1152767363"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Cash&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;1,324,398&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1257738491"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the&lt;br/&gt;  Three&#160;Months Ended&lt;br/&gt; March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Formation, general and administrative costs&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;282,307&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Interest  earned on investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;828,386&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The CODM reviews interest earned on the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The CODM reviews formation, general and administrative costs to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODM also reviews formation, general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Formation, general and administrative costs, as reported on the unaudited condensed statement of operations, are the significant segment expenses provided to the CODM on a regular basis. All other segment items included in net income or loss are reported on the unaudited condensed statement of operations and described within their respective disclosures.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_373897767" id="ixv-4093">The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the unaudited condensed statement of operations as net income or loss.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="cref_373897767" id="ixv-4094">When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%; text-align: left"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;230,828,386&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1152767363"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Cash&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;1,324,398&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1257738491"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;For the&lt;br/&gt;  Three&#160;Months Ended&lt;br/&gt; March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Formation, general and administrative costs&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;282,307&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Interest  earned on investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;828,386&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-4095"
      unitRef="uref_1548609138">230828386</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="cref_1489176576"
      decimals="0"
      id="ixv-4096"
      unitRef="uref_1548609138">1324398</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-4097"
      unitRef="uref_1548609138">282307</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_373897767"
      decimals="0"
      id="ixv-4098"
      unitRef="uref_1548609138">828386</us-gaap:InvestmentIncomeInterest>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_373897767" id="ixv-2584">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note 10&#160;&#x2014;&#160;Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date and through the date that the unaudited condensed financial statements is issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_373897767" id="ixv-4099">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_373897767" id="ixv-4100">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_373897767" id="ixv-4101">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_373897767" id="ixv-4102">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_1118528897"
          xlink:label="fc_1118528897"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1100698523"
          xlink:label="fc_1100698523"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_462183430"
          xlink:label="fc_462183430"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_380740556"
          xlink:label="fc_380740556"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_504481387"
          xlink:label="fc_504481387"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_12832729"
          xlink:label="fc_12832729"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_759636953"
          xlink:label="fc_759636953"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_334448824"
          xlink:label="fc_334448824"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1877463656"
          xlink:label="fc_1877463656"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1050704979"
          xlink:label="fc_1050704979"
          xlink:type="locator"/>
        <link:footnote id="fref_1904931758" xlink:label="fref_1904931758" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes up to 1,000,000 Class&#160;B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. In December&#160;2025, the Company issued additional 1,916,667 founder shares through a share capitalization resulting in the Sponsor holding 7,666,667 founder shares in the aggregate. All share and per-share data have been retrospectively presented (see Note&#160;5 and Note&#160;7). On February 20, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial Public Offering. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, 1,000,000 founder shares are no longer subject to forfeiture by the Sponsor (see Note 7).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1118528897"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1100698523"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_462183430"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_380740556"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_504481387"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_12832729"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_759636953"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_334448824"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1877463656"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1050704979"
          xlink:to="fref_1904931758"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_996730341"
          xlink:label="fc_996730341"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1309080258"
          xlink:label="fc_1309080258"
          xlink:type="locator"/>
        <link:footnote id="fref_660892015" xlink:label="fref_660892015" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes up to 1,000,000 Class&#160;B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On February 20, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial Public Offering. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, 1,000,000 founder shares are no longer subject to forfeiture by the Sponsor (see Note 7).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_996730341"
          xlink:to="fref_660892015"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1309080258"
          xlink:to="fref_660892015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1466992512"
          xlink:label="fc_1466992512"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1026691934"
          xlink:label="fc_1026691934"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_957446115"
          xlink:label="fc_957446115"
          xlink:type="locator"/>
        <link:footnote id="fref_1933729118" xlink:label="fref_1933729118" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes up to 1,000,000 Class&#160;B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. In December&#160;2025, the Company issued additional 1,916,667 founder shares through a share capitalization resulting in the Sponsor holding 7,666,667 founder shares in the aggregate. All share and per-share data have been retrospectively presented (see Note&#160;5 and Note&#160;7). On February 20, 2026, the underwriters exercised their over-allotment option in full to be settled as part of the closing of the Initial Public Offering. As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, 1,000,000 founder shares are no longer subject to forfeiture by the Sponsor (see Note 7).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1466992512"
          xlink:to="fref_1933729118"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1026691934"
          xlink:to="fref_1933729118"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_957446115"
          xlink:to="fref_1933729118"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
